Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells

• Main Authors: Yu-Zhu Zhang (Author), Jia-Yao Yang (Author), Rui-Xian Wu (Author), Chen Fang (Author), Hai Lu (Author), Hua-Chao Li (Author), Dong-Mei Li (Author), Hua-Li Zuo (Author), Li-Ping Ren (Author), Xiao-Yuan Liu (Author), Rui Xu (Author), Jia-Huai Wen (Author), Hsien-Da Huang (Author), Ri Hong (Author), Qian-Jun Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Xihuang pill, an approved Chinese medicine formula (state medical permit number. Z11020073), is a commonly used adjuvant drug for cancer patients in China. Xihuang pill has a satisfactory effect in treating breast cancer in clinics, especially triple-negative breast cancer (TNBC), which is the most...